GSK Pharmaceuticals’ revenue grows at seven per cent in Q1
For the quarter ended 30th June, 2019, GlaxoSmithKline Pharmaceuticals' Profit After Tax grew at 28 per cent
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
FDA grants approvals for generic Lyrica
The FDA granted approvals for the generic versions of Lyrica to Alembic Pharmaceuticals, Alkem Laboratories, Amneal…
Dr Reddy’s announces closure of the transaction to divest Zembrace SymTouch and Tosymra to…
The transaction, including the applicable waiting period, was completed under the Hart-Scott-Rodino Antitrust Improvements Act of…
Laurus Labs’ distribution partner Rising Pharmaceuticals launches Pregabalin Capsules in US market
Pregabalin Capsules and had US sales of approximately $5,497 million for the 12 months ending March 2019, according to IMS Health
InvaGen receives final approval for Pregabalin Capsules
InvaGen’s Pregabalin Capsule is AB-rated generic therapeutic equivalent version of Pfizer’s Lyrica
Lupin’s Nagpur facility won ENR Global Best Project Award
The award was given to Lupin’s Oral Solid Dosage (OSD) and Injectable Pharmaceutical Manufacturing Facility at Nagpur
Can pharmacy colleges act as big data enabler in pharmacovigilance?
Prof (Dr) Vandana Arora Sethi, Group Director, Lloyd Group of Institutions, talks about the rise in reporting on adverse drug…
Dr Reddy’s launches generic version of Allegra D in US
"We are pleased to be expanding our pseudoephedrine-based product offering in time for the cough, cold and allergy season," Dr…
Syngene appoints Dr Mahesh Bhalgat as COO
Dr Bhalgat is recognised for his contribution to the commercialisation of diagnostic kits, biopharmaceuticals and WHO…
Lupin Foundation organises Dr Desh Bandhu Gupta Memorial Lecture in New Delhi
The event hosted over 200 dignitaries